Financial statements Bader-Drog

Balance sheet of Bader-Drog

Company age:
Age:
13 y. 5 m. 17 d.
Share capital:
Share capital:
5 000 PLN

Balance sheet data of BADER-DROG

Year
2021
2022
2023
2024
Total assets 60 720,09 76 158,17 144 894,18 161 364,57
A. Fixed assets 1 000,00 1 000,00 1 000,00 1 000,00
B. Current assets 59 720,09 75 158,17 143 894,18 160 364,57
C. Share capital contributions (basic funds) 0,00 0,00 0,00 0,00
D. Own shares (stocks) 0,00 0,00 0,00 0,00
Total liabilities 60 720,09 76 158,17 144 894,18 161 364,57
A. Equity 35 871,82 -16 693,97 73 901,76 86 383,47
B. Liabilities and provisions for liabilities 24 848,27 92 852,14 70 992,42 74 981,10
I. Long-term liabilities 0,00 0,00 0,00 0,00
II. Short-term liabilities 24 848,27 92 852,14 70 992,42 74 981,10
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.

  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.